REHIT Versus SMIT in Sedentary Young Women

Sponsor
University of Valencia (Other)
Overall Status
Completed
CT.gov ID
NCT05875051
Collaborator
(none)
30
1
2
4.9
6.1

Study Details

Study Description

Brief Summary

Reduced-exertion high-intensity training (REHIT) is a novel form of exercise known for being non-classical, time-efficient, and effective on different populations. However, REHIT was scarcely tested on sedentary women with mortality risks. The aim of the study is to compare the effects of REHIT versus short moderate-intensity training (SMIT) on functional capacity, resting heart rate (RHR), and activity enjoyment in sedentary young women.

Condition or Disease Intervention/Treatment Phase
  • Other: Reduced-exertion high intensity training
  • Other: Short moderate intensity training
N/A

Detailed Description

The aim of the study is to compare the effects of reduced-exertion high-intensity training (REHIT) versus short moderate-intensity training (SMIT) on functional capacity, resting heart rate (RHR), and activity enjoyment in sedentary young women. Therefore, sedentary young women will be randomly allocated to either a: i) REHIT group or ii) SMIT group. Both groups will perform an intervention over 6 weeks duration for 10 minutes each session for 2 sessions/week, but with different intensities (REHIT or SMIT). Both forms of exercise will be conducted on a cycle ergometer with the subjects monitored throughout the intervention. Before and after the 3-week intervention, functional capacity (6-minute walking test) and RHR will be measured. Additionally, physical activity enjoyment (Physical Activity Enjoyment Scale) will be assessed after the intervention.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
The outcomes assessor will be blinded to treatment group allocation. The blinded assessor will collect all baseline and post-intervention measures and enter data.
Primary Purpose:
Treatment
Official Title:
Effects of Reduced-exertion High-intensity Training Versus Short Moderate Intensity Training on Functional Capacity and Physical Activity Enjoyment in Sedentary Young Women A Randomized Trial
Actual Study Start Date :
Dec 1, 2021
Actual Primary Completion Date :
Apr 30, 2022
Actual Study Completion Date :
Apr 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Reduced-exertion high intensity training group

The REHIT part will consist of maximum cycling sprints of all-out exercise at 100% of the HRmax, increasing for up to 10 seconds, 15 seconds on week two and 20 seconds on week three.

Other: Reduced-exertion high intensity training
The intervention of the REHIT group will consist of three parts: i) 3 minutes of warm-up part at 50% of HRmax obtained in the effort test; ii) 3 min 20 sec to 3 min 40 sec of REHIT; and iii) 3 minutes of cool-down at 50% of HRmax obtained in the effort test. The REHIT part will consist of maximum cycling sprints of all-out exercise at 100% of the HRmax, increasing for up to 10 seconds, 15 seconds on week two and 20 seconds on week three. Then, 3 minutes of active rest at 50% of HRmax. Finally, 10 seconds of all-out exercise at 100% of the HRmax, rising to 15 seconds on week two and 20 seconds on week three.

Active Comparator: Short moderate intensity training group

The SMIT part of the session will consist of 6 minutes of moderate intensity exercise at 60-70% HRmax.

Other: Short moderate intensity training
The SMIT group will receive a short moderate-intensity training with the same warm-up and cool-down exercises as the REHIT group. In addition, the main part of the session consisted of 6 minutes of moderate intensity exercise at 60-70% HRmax obtained in the effort test. In addition, the main part of the session increases 3 min every week as 6 min for the first 2 weeks, 9 min for the 3rd and 4th weeks, and 12 min for the last two weeks.

Outcome Measures

Primary Outcome Measures

  1. Functional capacity [Baseline]

    It will be measured using the 6-minutes walking test (6MWT). Participants will be instructed to walk as quickly as possible along a 30-meter hallway for a duration of six minutes without running. Then, the distance in meters they cover will be registered. The greater the number of meters run, the better the functional capacity.

  2. Functional capacity [After the intervention (3 weeks)]

    It will be measured using the 6-minutes walking test (6MWT). Participants will be instructed to walk as quickly as possible along a 30-meter hallway for a duration of six minutes without running. Then, the distance in meters they cover will be registered. The greater the number of meters run, the better the functional capacity.

Secondary Outcome Measures

  1. Resting heart rate [Baseline]

    It will be measured with a patient monitor (ProAct PC-3000 Patient Monitor, Medisave, UK).

  2. Resting heart rate [After the intervention (3 weeks)]

    It will be measured with a patient monitor (ProAct PC-3000 Patient Monitor, Medisave, UK).

  3. Physical activity enjoyment [Baseline]

    To assess enjoyment, a modified version of the Physical Activity Enjoyment Scale (PACES) will be used. In this questionnaire, 17 items are scored on a 7-point bipolar scale, with an overall enjoyment score ranging from 17 (not enjoyable) to 68 (neutral) and 119 (enjoyable).

  4. Physical activity enjoyment [After the intervention (3 weeks)]

    To assess enjoyment, a modified version of the Physical Activity Enjoyment Scale (PACES) will be used. In this questionnaire, 17 items are scored on a 7-point bipolar scale, with an overall enjoyment score ranging from 17 (not enjoyable) to 68 (neutral) and 119 (enjoyable).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 25 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women.

  • Age between 18 and 25 years old.

  • Those who score a low physical activity level (< 600 METS min/week) in the International Physical Activity Questionnaire-short form.

Exclusion Criteria:
  • Women who suffer from musculoskeletal.

  • Women who suffer from neurological diseases.

  • Those who are taking medications.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Valencia Valencia Spain 46010

Sponsors and Collaborators

  • University of Valencia

Investigators

  • Principal Investigator: Elena Marqués Sulé, PhD, Univeristy of Valencia

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Elena Marques-Sule, Professor, University of Valencia
ClinicalTrials.gov Identifier:
NCT05875051
Other Study ID Numbers:
  • 035/3/20
First Posted:
May 25, 2023
Last Update Posted:
May 25, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Elena Marques-Sule, Professor, University of Valencia

Study Results

No Results Posted as of May 25, 2023